NoBACZ - company
28 employees on LinkedIn · 8 known investors
Find your way into NoBACZ - company
17 people in our graph share verified history with the NoBACZ - company team — schools, employers, funds. One of them is your warm intro.
Andrewunlockedknows Jonathan Powell · together at Adjuvo
×11knows the team · via Adjuvo
NoBACZ Healthcare develops antibiotic-free, patented liquid barrier products for wound and lesion management, creating waterproof physical barriers that block microbes as an alternative to topical antimicrobials. Its biodegradable formulas target animal health applications such as protecting hooves, horn buds and udders in farm environments, with active research collaborations with universities.
Founders & leadership
JP
Jonathan PowellinJonathan Powell is CEO of NoBACZ Healthcare, a University of Cambridge spin-out developing antibiotic-free wound care products for veterinary applications. He holds a Research Professor position at Cambridge and has over 30 years of experience in biomedical research, including prior roles at the MRC and King's College London, with expertise in biomineral science and nanomedicine.
Investors · 8
Competitors · 1
by search overlap
Companies competing with NoBACZ - company for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does NoBACZ - company do?
- NoBACZ Healthcare develops antibiotic-free, patented liquid barrier products for wound and lesion management, creating waterproof physical barriers that block microbes as an alternative to topical antimicrobials. Its biodegradable formulas target animal health applications such as protecting hooves, horn buds and udders in farm environments, with active research collaborations with universities.
- Who are NoBACZ - company's investors?
- NoBACZ - company's investors include Adjuvo, Cambridge Angels group, EMV Capital, Martlet Capital, The FSE Group, The Yield Lab Europe, ACF Investors, The Yield Lab.